The Health Care Business of LexisNexis Risk Solutions Continues Growth Trajectory With New Leadership Appointments

The Health Care business of LexisNexis® Risk Solutions announced today that Dave Corbett has joined the organization as head of Sales and Client Engagement and Jeff Diamond has been promoted to senior vice president of Commercial Operations.

The Health Care business of LexisNexis® Risk Solutions announced today that Dave Corbett has joined the organization as head of Sales and Client Engagement and Jeff Diamond has been promoted to senior vice president of Commercial Operations. 

Corbett has spent his entire career in health care IT focused on sales excellence and client relationship development. He will have full responsibility for all sales growth initiatives across all health care verticals within the business. Prior to LexisNexis Risk Solutions, Corbett led sales for over a decade at Optum/United Health Group in both their Provider and Clinical Solutions markets. Earlier in his career Corbett held sales and business development leadership roles at SAP, Lawson Software/Infor and Shared Medical Systems. In this role, Corbett will provide senior leadership over field sales, sales operations, and vendor partnerships as well as the account management and solution consultant teams.  

“I couldn’t be more excited about the addition of Dave to lead our sales organization,” said Josh Schoeller, chief executive officer at the Health Care business of LexisNexis Risk Solutions. “He brings tremendous experience in nurturing client relationships and leading high-performing sales teams that will help us deliver more value for our clients. He also adds deep health care thought leadership to our team and will ensure our strategy and market execution are industry leading.”

With this addition, Jeff Diamond – a company veteran of more than 12 years – has been promoted to senior vice president of Commercial Operations. In addition to his most recent role leading the Sales organization, Diamond has held senior leadership roles across the Health Care business including Product Management and Analytics, Market Planning, and Operations/Professional Services. Diamond will continue to provide senior leadership for commercial functions while also ensuring the business operates and innovates at its current high growth rate to extend its role as the leader in trusted health care data, analytics and insights for payer, provider, retail pharmacy and life sciences organizations. 

“Jeff is one of the strongest business operators I’ve worked with,” said Schoeller. “He has deep expertise across every facet of our business and he truly understands the needs of our customers. He has been a key contributor to our historical growth and will continue to optimize our execution and growth functions for many years to come.”

About LexisNexis Risk Solutions 
LexisNexis® Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, health care and government. Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information-based and analytics and decision tools for professional and business customers across industries. For more information, please visit www.risk.lexisnexis.com and www.relx.com.  

Total
0
Shares
Leave a Reply
Related Posts
Read More

BioIQ Launches Telehealth Enabled At-Home Saliva Test Kit for COVID-19 with P23 Labs

BioIQ, a healthcare engagement and clinical adherence technology platform company, announces the availability of an at-home RT-PCR COVID-19 testing solution with fully integrated telehealth support. The test is being offered in partnership with P23 Labs, one of the first laboratories to receive Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for home saliva collection in conjunction with telehealth oversight. The partnership enables BioIQ to connect employees, health plan members, and individuals with COVID-19 diagnostic testing under the virtual supervision of a clinician.
Read More

Senior Vice President of Randstad Engineering Angie Keller to Moderate All-Women Panel at 2019 Sensors Expo & Conference

Randstad US is pleased to announce Angie Keller, senior vice president of Randstad Engineering, will moderate the Women in Sensors Engineering (WISE) Program panel discussion at the 2019 Sensors Expo & Conference. The session will provide a platform for engineers to hear from female leadership, share their contributions to the sensors community and solicit advice. Panelists include:

Emil Kakkis Joins Nonprofit Biotech Odylia Therapeutics Board of Directors

Emil Kakkis, MD, PhD, joins the Board of Directors of Odylia Therapeutics. Kakkis is the CEO, President and Founder of Ultragenyx Pharmaceutical Inc., which is committed to developing and commercializing treatments for rare and ultra-rare diseases. He brings to Odylia knowledge of the needs and opportunities in developing life-altering therapies for rare diseases. Dr. Kakkis states "Odylia is a unique organization with the potential to truly shift the way therapies are brought to market, ultimately bringing life changing treatments to people living with rare diseases. I'm looking forward to being part of their work."